Latanoprost/timolol fixed combination for the treatment of glaucoma


Konstas A. G. P. , MOCAN M. C. , Katsanos A., Voudouragkaki I. C. , Irkec M.

EXPERT OPINION ON PHARMACOTHERAPY, cilt.14, ss.1815-1827, 2013 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 14 Konu: 13
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1517/14656566.2013.813482
  • Dergi Adı: EXPERT OPINION ON PHARMACOTHERAPY
  • Sayfa Sayıları: ss.1815-1827

Özet

Introduction: Glaucoma is a multifactorial optic neuropathy that can lead to progressive and irreversible loss of vision. Today there are > 60 million glaucoma patients worldwide, and this figure is rising due to aging. The aim of glaucoma therapy is to maintain the patient's visual function and quality of life by means of intraocular pressure (IOP) reduction, which currently constitutes the only evidence-based approach.